JPMorgan Chase & Co. upgraded shares of Intel (NASDAQ:INTC – Free Report) from an underweight rating to a neutral rating in a research report released on Monday morning, MarketBeat Ratings reports. The firm currently has $85.00 price objective on the chip maker’s stock. Several other brokerages have also recently issued reports on INTC. Barclays raised […]

Fomento Economico Mexicano (NYSE:FMX – Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Friday, Marketbeat reports. The brokerage currently has a $151.00 price objective on the stock. JPMorgan Chase & Co.‘s target price would […]

Brighthouse Financial (NASDAQ:BHF – Get Free Report) was upgraded by research analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The firm presently has a $55.00 price target on the stock. JPMorgan Chase & Co.‘s price objective […]

ArcelorMittal (NYSE:MT – Get Free Report) was upgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Thursday, Marketbeat reports. MT has been the topic of several other reports. Morgan Stanley assumed coverage on shares of ArcelorMittal in a research note on […]

JPMorgan Chase & Co. upgraded shares of V.F. (NYSE:VFC – Free Report) from an underweight rating to a neutral rating in a report released on Friday morning, Marketbeat reports. JPMorgan Chase & Co. currently has $18.00 price target on the textile maker’s stock. VFC has been the subject of several other research reports. Telsey Advisory […]

JPMorgan Chase & Co. upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from an underweight rating to a neutral rating in a report issued on Thursday,Benzinga reports. The firm currently has $36.50 price target on the stock. A number of other research analysts also recently issued reports on PCRX. Jefferies Financial Group downgraded shares […]